7.19
                                            전일 마감가:
              $7.10
            열려 있는:
              $7.09
            하루 거래량:
                106.76K
            Relative Volume:
              0.65
            시가총액:
                $269.17M
            수익:
              $128.45M
            순이익/손실:
              $6.54M
            주가수익비율:
              143.80
            EPS:
                0.05
            순현금흐름:
                $-8.79M
            1주 성능:
              +6.05%
            1개월 성능:
              -2.31%
            6개월 성능:
                +6.36%
            1년 성능:
              +26.58%
            Lifecore Biomedical Inc Stock (LFCR) Company Profile
명칭
                  
                      Lifecore Biomedical Inc
                    
                전화
                  
                      (952) 368-4300
                    
                주소
                  
                      3515 LYMAN BOULEVARD, CHASKA
                    
                LFCR을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 | 
|---|---|---|---|---|---|---|
|   
                          
                                LFCR
                            
                             Lifecore Biomedical Inc | 7.19 | 266.01M | 128.45M | 6.54M | -8.79M | 0.05 | 
|   
                          
                                ZTS
                            
                             Zoetis Inc | 144.09 | 63.86B | 9.39B | 2.62B | 2.22B | 5.8121 | 
|   
                          
                                TAK
                            
                             Takeda Pharmaceutical Co Adr | 13.44 | 41.80B | 29.96B | 957.25M | 4.77B | 0.2956 | 
|   
                          
                                HLN
                            
                             Haleon Plc Adr | 9.27 | 40.88B | 14.26B | 1.98B | 2.47B | 0.4327 | 
|   
                          
                                TEVA
                            
                             Teva Pharmaceutical Industries Ltd Adr | 20.48 | 22.98B | 16.70B | -157.13M | 1.19B | -0.1446 | 
|   
                          
                                UTHR
                            
                             United Therapeutics Corp | 445.43 | 19.53B | 3.08B | 1.24B | 1.07B | 25.61 | 
Lifecore Biomedical Inc Stock (LFCR) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 | 
|---|---|---|---|
| 2025-09-04 | 개시 | KeyBanc Capital Markets | Sector Weight | 
| 2025-05-21 | 개시 | William Blair | Outperform | 
| 2024-09-05 | 개시 | Craig Hallum | Buy | 
| 2024-08-28 | 다운그레이드 | Barrington Research | Outperform → Mkt Perform | 
| 2023-03-20 | 다운그레이드 | Stephens | Overweight → Equal-Weight | 
Lifecore Biomedical Inc 주식(LFCR)의 최신 뉴스
Lifecore Biomedical Approves Key Proposals at Annual Meeting - TipRanks
Why pension funds invest in Lifecore Biomedical Inc. (LDE) stock2025 Volume Leaders & Technical Analysis for Trade Confirmation - newser.com
Why millennials buy Lifecore Biomedical Inc. (LDE) stockJuly 2025 Fed Impact & Consistent Profit Trading Strategies - newser.com
Can Lifecore Biomedical Inc. stock beat market expectations this quarterPortfolio Return Report & Weekly High Momentum Picks - newser.com
Is Lifecore Biomedical Inc. (LDE) stock suitable for passive index fundsJuly 2025 Selloffs & Technical Entry and Exit Alerts - newser.com
Will Lifecore Biomedical Inc. (LDE) stock gain from lower interest ratesJuly 2025 Momentum & Daily Profit Focused Screening - newser.com
Is Lifecore Biomedical Inc. (LDE) stock undervalued after correction2025 Support & Resistance & Fast Gain Swing Alerts - newser.com
Is Lifecore Biomedical Inc. forming a reversal patternJuly 2025 Analyst Calls & Real-Time Stock Price Movement Reports - newser.com
What catalysts could drive Lifecore Biomedical Inc. stock higher2025 Trading Volume Trends & Fast Moving Market Watchlists - newser.com
Can Lifecore Biomedical Inc. stock weather global recessionGlobal Markets & Expert Approved Trade Ideas - newser.com
Is Lifecore Biomedical Inc. stock affected by interest rate hikesIndex Update & Weekly Breakout Stock Alerts - newser.com
Lifecore Biomedical to Report Financial Results for the Three Months Ended September 30, 2025, on November 6, 2025 - The Manila Times
Bronstein, Gewirtz & Grossman, LLC Is Investigating Lifecore Biomedical, Inc. (LFCR) And Encourages Investors to Connect - ACCESS Newswire
Here’s Why Lifecore Biomedical Inc (LFCR) Declined 22% at the End of Q3 - Insider Monkey
Will Lifecore Biomedical Inc. outperform the marketPrice Action & Precise Trade Entry Recommendations - newser.com
Key metrics from Lifecore Biomedical Inc.’s quarterly data2025 Top Gainers & Community Verified Trade Signals - newser.com
Can Lifecore Biomedical Inc. stock surprise with earnings upsidePortfolio Risk Summary & Risk Controlled Daily Trade Plans - newser.com
What hedge fund moves indicate for Lifecore Biomedical Inc. (LDE) stock2025 EndofYear Setup & Fast Momentum Entry Tips - newser.com
Will Lifecore Biomedical Inc. (LDE) stock benefit from infrastructure billGold Moves & Short-Term Swing Trade Alerts - newser.com
Is it too late to sell Lifecore Biomedical Inc.Quarterly Profit Review & Safe Entry Trade Reports - newser.com
Lifecore signs agreement with leading global pharmaceutical company - TipRanks
Lifecore Selected as Commercial Mfg. Partner for Leading Injectable Product - Contract Pharma
Lifecore Biomedical Selects as New Commercial Manufacturing Partner by Leading Global Pharmaceutical Company - MarketScreener
What analysts say about Lifecore Biomedical Inc stockTrend Following Strategies & Outstanding Growth Portfolio - earlytimes.in
Lifecore (NASDAQ: LFCR) to transfer manufacturing; second agreement with same multinational - Stock Titan
Lifecore and PolyPeptide link for US peptide manufacturing - Yahoo Finance
Will Lifecore Biomedical Inc. (LDE) stock see insider accumulationJuly 2025 Sector Moves & Free Safe Capital Growth Stock Tips - newser.com
Real time pattern detection on Lifecore Biomedical Inc. stockGap Down & Free High Accuracy Swing Entry Alerts - newser.com
Lifecore, PolyPeptide Partner on Peptide Manufacturing Solution for U.S. Market - Contract Pharma
What sentiment indicators say about Lifecore Biomedical Inc. stockWeekly Investment Report & Smart Investment Allocation Insights - Fundação Cultural do Pará
Lifecore, PolyPeptide collab to offer peptide manufacturing solution - TipRanks
Bronstein, Gewirtz & Grossman, LLC Is Investigating Lifecore Biomedical, Inc. (LFCR) And Encourages Stockholders to Connect - ACCESS Newswire
Lifecore, PolyPeptide Partner on Peptide Manufacturing for U.S. Market - Contract Pharma
Lifecore Biomedical, Inc. and Polypeptide Laboratories, Inc. Announce Collaboration Intended to Offer End-To-End Peptide Manufacturing Solution for U.S. Market - MarketScreener
Lifecore and PolyPeptide partner on integrated peptide manufacturing By Investing.com - Investing.com Nigeria
Lifecore and PolyPeptide partner on integrated peptide manufacturing - Investing.com
Will Lifecore Biomedical Inc. (LDE) stock recover faster than industry2025 Trading Recap & Scalable Portfolio Growth Methods - newser.com
Lifecore and PolyPeptide Announce Collaboration Intended to Offer End-to-End Peptide Manufacturing Solution for U.S. Market - The Manila Times
Lifecore Biomedical and PolyPeptide Laboratories Announce Collaboration to Enhance Peptide-Based Pharmaceutical Development - Quiver Quantitative
Lifecore (NASDAQ: LFCR), PolyPeptide sign U.S. DS-to-DP peptide collaboration - Stock Titan
Lifecore Biomedical Inc (LFCR) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Lifecore Biomedical Inc 주식 (LFCR) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 | 
|---|---|---|---|---|---|---|---|
| English Aron R. | 10% Owner | May 28 '25 | Sale | 7.12 | 150,419 | 1,071,555 | 264,180 | 
| English Aron R. | 10% Owner | May 23 '25 | Sale | 6.75 | 96,137 | 649,386 | 1,554,103 | 
| English Aron R. | 10% Owner | May 13 '25 | Sale | 7.00 | 12,334 | 86,353 | 1,650,240 | 
| English Aron R. | 10% Owner | May 12 '25 | Sale | 7.03 | 45,698 | 321,426 | 1,662,574 | 
| English Aron R. | 10% Owner | May 08 '25 | Sale | 7.00 | 5,098 | 35,693 | 1,708,972 | 
| English Aron R. | 10% Owner | May 09 '25 | Sale | 7.00 | 700 | 4,900 | 1,708,272 | 
| English Aron R. | 10% Owner | May 05 '25 | Sale | 7.08 | 24,543 | 173,831 | 1,730,618 | 
| English Aron R. | 10% Owner | May 07 '25 | Sale | 7.01 | 15,847 | 111,099 | 1,714,070 | 
| English Aron R. | 10% Owner | May 06 '25 | Sale | 7.05 | 701 | 4,940 | 1,729,917 | 
| Josephs Paul | Chief Executive Officer | Jan 08 '25 | Buy | 5.74 | 17,000 | 97,580 | 559,717 | 
                자본화:
                 
                  | 
                볼륨(24시간):
                 
            
         
                     
                             Stockscreener 앱 받기
                    Stockscreener 앱 받기